Jade Biosciences, Inc. press release (JBIO): Q1 GAAP EPS of -$0.57 misses by $0.09. – As of March 31, 2026, Jade had cash, cash equivalents, and investments of $311.3M. – Net loss totaled $40.4M for the first quarter ended March 31, 2026, compared to $38.2M for the quarter ended…
Jade Biosciences, Inc. GAAP EPS of -$0.57 Misses by $0.09
Jade Biosciences, Inc. press release (JBIO): Q1 GAAP EPS of -$0.57 misses by $0.09. - As of March 31, 2026, Jade had cash, cash equivalents, and investments of $311.3M. - Net loss totaled $40.4M for the first quarter ended March 31, 2026, compared to $38.2M for the quarter ended...</stron